SYM-210: Communicating and Evaluating Adverse Events Associated with an FDA-Approved Medical Device

The 2019 ASCRS FDA symposium will spotlight the FDA efforts to assure the safety and effectiveness of medical technologies used in the United States. Specifically, this symposium will address the FDA’s process for evaluating adverse events associated with an FDA-approved medical device and those that have been withdrawn from the market.

Filed Under

Practice Management healthcare new technology legislative politics FDA safety